Patients with mild hypertensive heart disease and left ventricular outflow tract obstruction: Treatment with angiotensin II antagonists

Heart and Vessels

Volumn 19, Issue 5, 2004, Pages 248-251

  Nakagawa, Mikiko ^a   Sano, Nario ^a   Nobe, Seiki ^a   Ichinose, Masashi ^a   Yonemochi, Hidetoshi ^a   Saikawa, Tetsunori ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Angiotensin II antagonist; Hypertension; Hypertrophy; Left ventricular outflow tract obstruction; Systolic anterior motion of mitral leaflet

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN;

ADULT; AGED; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG CHOICE; ECHOCARDIOGRAPHY; FEMALE; GERIATRIC PATIENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTENSION; MALE; MITRAL VALVE; PRESSURE GRADIENT; PRIORITY JOURNAL; SYSTOLIC HEART MURMUR;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL CONTRACTION; TETRAZOLES; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 5044224466     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0756-2     Document Type: Article

References (13)

1. Agatston AS, Polakoff R, Hippogoankar R, Schnur S, Samet P (1989) The significance of increased left ventricular outflow tract velocities in the elderly measured by continuous wave Doppler. Am Heart J 117:1320-1326
2. Harrison MR, Grigsby CG, Souther SK, Smith MD, DeMaria AN (1991) Midventricular obstruction associated with chronic systemic hypertension and severe left ventricular hypertrophy. Am J Cardiol 68:761-765
3. Wheeldom NM, Pringle TH, Lipworth BJ (1992) Obstructive left ventricular hypertrophy. Reversibility of outflow tract obstruction by drug therapy. Q J Med 84:629-636
4. Faber L, Heemann A, Sürig M, Michalowski Z, Gleichmann U, Klempt HW (1998) Outflow acceleration assessed by continuous-wave Doppler echocardiography in left ventricular hypertrophy: an analysis of 103 consecutive cases. Cardiology 90:220-226
5. Sgreccia A, Morabito G, Gurgo Di Castelmenardo A, Bernardo ML, Petrilli AC, De Leva R, De Marzio P, Nuccio F, Morelli S (2001) Congestive heart failure in hypertensive patients with normal systolic function and dynamic left ventricular outflow obstruction. Minerva Cardioangiol 49:99-106
6. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Circulation 55:613-618
7. Arita M, Fujiwara S, Ueno Y, Shiotani M, Nakamura Y, Nakatsu C, Nishio I, Masuyama Y (1990) Regression of left ventricular hypertrophy in hypertensive patients: responses to exercise by antihypertensive treatment. Jpn Circ J 54:575-580
8. Devereux RB, Palmieri V, Sharpe N, De Quattro V, Bella JN, de Simone G, Walker JF, Hahn RT, Dahlöf B (2001) Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension. The prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial. Circulation 104: 1248-1254
9. Mitsunami K, Inoue S, Maeda K, Endoh S, Takahashi M, Okada M, Sugihara H, Kinoshita M (1998) Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther 12:469-474
10. Dahlof B (2001) Left ventricular hypertrophy and angiotensin II antagonists. Am J Hypertens 14:174-182
11. Dendorfer A, Raasch W, Tempel K, Dominiak P (1998) Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol 93:24-29
12. 123I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure. Heart Vessels 17:47-52
13. Nunoda S, Genda A, Sekiguchi M, Takeda R (1985) Left ventricular endomyocardial biopsy findings in patients with essential hypertension and hypertrophic cardiomyopathy with special reference to the incidence of bizarre myocardial hypertrophy with disorganization and biopsy score. Heart Vessels 1:170-175